King Solomon to Saint Mary: a journey through human retroviruses, ancien...
Ζωντανή μετάδοση στις 19 Νοε 2015
Explore
Imperial’s success in treating human T-lymphotropic virus and how
parallel research into HIV and HTLV provides insights into both
infections.
Interact online via the hashtag #retroviral.
Human
T-lymphotropic virus type 1 (HTLV-1) slips under the radar of most
healthcare workers, especially compared to its distant relative – HIV.
With 10 million infections globally and twenty thousand carrying HTLV-1
in the UK alone this infection is neglected even amongst neglected
diseases. Whilst infection does not cause symptoms in the majority, 1 in
10 are at risk of either aggressive forms of white blood cell cancers
or inflammation in many tissues. Inflammation of the spinal cord causes
decades of disability. Parallel research into HIV and HTLV provides
useful insights into both infections.
In his lecture Professor
Taylor will chart the successes of the largest HTLV research centre in
Europe, here at Imperial. At St. Mary’s his team have, over the last 22
years, cared for those affected by HTLV, developed tests to monitor
infection and explored treatments old and new.
The virtual
elimination of HIV mother-to-child transmission and normalisation of the
management of pregnancy for HIV infected mothers in the UK has been
achieved with little fanfare. Professor Taylor will show how clinical
research at Imperial has contributed to our knowledge on prevention of
transmission, often leading the global debate on safety and
effectiveness of anti-HIV therapy in pregnancy.
Graham P Taylor
is Professor of Human Retrovirology at Imperial College London and an
Honorary Consultant and Lead Clinician within the National Centre for
Human Retrovirology at St. Mary’s Hospital London
He qualified MB
ChB from the University of Birmingham Medical School, England and
trained in General Internal Medicine in the West Midlands and South
Wales before being appointment as Chief Medical Officer (Medicine) for
the Solomon Islands. In 1992 he joined the Section of Infectious
Diseases, Imperial College Faculty of Medicine (formerly St. Mary’s
Hospital Medical School) and was awarded DSc in 2012 before being
appointed Professor of Human Retrovirology in 2013.
Imperial’s success in treating human T-lymphotropic virus and how
parallel research into HIV and HTLV provides insights into both
infections.
Interact online via the hashtag #retroviral.
Human
T-lymphotropic virus type 1 (HTLV-1) slips under the radar of most
healthcare workers, especially compared to its distant relative – HIV.
With 10 million infections globally and twenty thousand carrying HTLV-1
in the UK alone this infection is neglected even amongst neglected
diseases. Whilst infection does not cause symptoms in the majority, 1 in
10 are at risk of either aggressive forms of white blood cell cancers
or inflammation in many tissues. Inflammation of the spinal cord causes
decades of disability. Parallel research into HIV and HTLV provides
useful insights into both infections.
In his lecture Professor
Taylor will chart the successes of the largest HTLV research centre in
Europe, here at Imperial. At St. Mary’s his team have, over the last 22
years, cared for those affected by HTLV, developed tests to monitor
infection and explored treatments old and new.
The virtual
elimination of HIV mother-to-child transmission and normalisation of the
management of pregnancy for HIV infected mothers in the UK has been
achieved with little fanfare. Professor Taylor will show how clinical
research at Imperial has contributed to our knowledge on prevention of
transmission, often leading the global debate on safety and
effectiveness of anti-HIV therapy in pregnancy.
Graham P Taylor
is Professor of Human Retrovirology at Imperial College London and an
Honorary Consultant and Lead Clinician within the National Centre for
Human Retrovirology at St. Mary’s Hospital London
He qualified MB
ChB from the University of Birmingham Medical School, England and
trained in General Internal Medicine in the West Midlands and South
Wales before being appointment as Chief Medical Officer (Medicine) for
the Solomon Islands. In 1992 he joined the Section of Infectious
Diseases, Imperial College Faculty of Medicine (formerly St. Mary’s
Hospital Medical School) and was awarded DSc in 2012 before being
appointed Professor of Human Retrovirology in 2013.
Κατηγορία
Άδεια
- Τυπική άδεια YouTube
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου